Search Result "Spike glycoprotein"
Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2021 Page: 640-642
Author(s): Bipin Singh
Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD)of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein fromTriphala Through Molecular Docking
Journal: Current Chinese Chemistry
Volume: 2 Issue: 1 Year: 2022 Page: 74-84
Author(s): Sharuk L. Khan,Falak A. Siddiqui,Mohd Sayeed Shaikh,Nitin V. Nema,Aijaz A. Shaikh
Identification of Conserved Epitopes in SARS-CoV-2 Spike and NucleocapsidProtein
Journal: Current Genomics
Volume: 22 Issue: 7 Year: 2021 Page: 541-549
Author(s): Andrea Giansanti,Maddalena Dilucca,Anna Benedetti,Sergio Forcelloni
In Silico Identification of New Anti-SARS-CoV-2 Agents from Bioactive Phytocompounds Targeting the Viral Spike Glycoprotein and Human TLR4
Journal: Letters in Drug Design & Discovery
Volume: 19 Issue: 3 Year: 2022 Page: 175-191
Author(s): Nabarun Chandra Das,Rajendra Kumar Labala,Ritwik Patra,Asamanja Chattoraj
Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design
Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 29 Year: 2022 Page: 2396-2409
Author(s): M. Michael Gromiha
CD4-Induced Epitopes in the HIV Envelope Glycoprotein, Gp120
Journal: Current HIV Research
Volume: 5 Issue: 6 Year: 2007 Page: 561-571
Author(s): Anthony L. DeVico
Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 9 Year: 2021 Page: 915-931
Author(s): Falak A. Siddiqui,Sharuk L. Khan,Rajendra P. Marathe,Nitin V. Nema
In silico Evaluation of Anacyclus pyrethrum Composition for Inhibition of Spike RBD-ACE-2 Interaction to Treat COVID-19
Journal: Coronaviruses
Volume: 5 Issue: 0 Year: 2024 Page: 1-14
Author(s): Anand Kumar Pandey
State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP)Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 46 Year: 2022 Page: 3706-3719
Author(s): Mohammad Azam Ansari,Mohammad N. Alomary,Qazi Mohammad Sajid Jamal,Suliman A. Almahmoud
Rational Modifications of HIV-1 Envelope Glycoproteins for Immunogen Design
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 213-227
Author(s): S. Phogat, R. Wyatt